Page last updated: 2024-09-04

isovitexin and Gouty Arthritis

isovitexin has been researched along with Gouty Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Li, P; Liu, W; Qu, X; Sun, X	1

Other Studies

1 other study(ies) available for isovitexin and Gouty Arthritis

Article	Year
Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway. Pharmaceutical biology, 2021, Volume: 59, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Arthritis, Gouty; Colchicine; Disease Models, Animal; Inflammation; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Sulfonamides; Toll-Like Receptor 4	2021

Article

Year

Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway.

Pharmaceutical biology, 2021, Volume: 59, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Arthritis, Gouty; Colchicine; Disease Models, Animal; Inflammation; Male; Myeloid Differentiation Factor 88; NF-kappa B; Rats; Rats, Sprague-Dawley; Sulfonamides; Toll-Like Receptor 4

2021